Combination Delapril/Manidipine as Antihypertensive Therapy in High-Risk Patients

被引：0
作者：
Roberto Fogari
Amedeo Mugellini
Maria Circelli
Giovanni Cremonesi
机构：
[1] University of Pavia,Department of Internal Medicine and Therapeutics
[2] Chiesi Farmaceutici SpA,Medical Department
[3] Policlinico S. Matteo,Clinica Medica II
来源：
Clinical Drug Investigation | 2011年 / 31卷
关键词：
Enalapril; Amlodipine; Antihypertensive Agent; Irbesartan; Ambulatory Blood Pressure Monitoring;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The majority of patients with hypertension, and in particular high-risk patients or those with diabetes mellitus or renal dysfunction, are likely to require combination therapy with at least two antihypertensive agents (from different classes) to achieve their blood pressure (BP) target. The delapril/manidipine fixed-dose combination consists of two antihypertensive agents with different, yet complementary, mechanisms of action. Delapril/manidipine has demonstrated short- and long-term antihypertensive efficacy in a number of clinical studies in patients with hypertension with an inadequate response to monotherapy.
引用
收藏
页码：439 / 453
页数：14
相关论文
共 50 条
  • [31] Who should be considered for initial therapy with combination antihypertensive agents?
    Bakris, GL
    AMERICAN JOURNAL OF HYPERTENSION, 2003, 16 (05) : 264A - 264A
  • [32] Extending the benefits of combination antihypertensive therapy to morbidity and mortality reduction
    Dahlöf, B
    AMERICAN JOURNAL OF HYPERTENSION, 2004, 17 (05) : 248A - 248A
  • [33] Extending the benefits of combination antihypertensive therapy to morbidity and mortality reduction
    Pitt, B
    AMERICAN JOURNAL OF HYPERTENSION, 2005, 18 (05) : 268A - 269A
  • [34] Antihypertensive Therapy With CCB/ARB Combination in Older Individuals: Focus on Amlodipine/Valsartan Combination
    Kostis, John B.
    AMERICAN JOURNAL OF THERAPEUTICS, 2010, 17 (02) : 188 - 196
  • [35] Treatment of high-risk hypertensive patients: Unresolved issues revised by staging the risk
    Ruilope L.M.
    Segura J.
    Tocci G.
    Volpe M.
    High Blood Pressure & Cardiovascular Prevention, 2006, 13 (1) : 13 - 19
  • [36] Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients
    Lloyd-Jones D.M.
    Current Cardiovascular Risk Reports, 2009, 3 (4) : 233 - 234
  • [37] The impact of statins addind to the fixed combination antihypertensive therapy on the arterial stiffness in patients with moderate and severe hypertension
    Sirenko, Yuriy
    Rekovets, Oksana
    INTERNATIONAL JOURNAL OF CARDIOLOGY CARDIOVASCULAR RISK AND PREVENTION, 2023, 18
  • [38] Combined antihypertensive therapy in patients with abdominal obesity
    Belyaeva, O. D.
    Bazhenova, E. A.
    Bolshakova, O. O.
    Berezina, A., V
    Berkovich, O. A.
    Baranova, E. I.
    RUSSIAN JOURNAL OF CARDIOLOGY, 2009, (04): : 43 - 48
  • [39] The therapeutic advantage of combination antihypertensive drug therapy using amlodipine and irbesartan in hypertensive patients: Analysis of the post-marketing survey data from PARTNER (Practical combination therapy of Amlodin and angiotensin II Receptor blocker; safety and efficacy in patients with hypertension) study
    Ishimitsu, Toshihiko
    Fukuda, Hirofumi
    Uchida, Masako
    Ishibashi, Kazushi
    Sato, Fusako
    Nukui, Kazuhiko
    Nagao, Munehiko
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 2015, 37 (07) : 542 - 550
  • [40] Rationale, study design and implementation of the COLM study: the combination of OLMesartan and calcium channel blocker or diuretic in high-risk elderly hypertensive patients
    Ogihara, Toshio
    Saruta, Takao
    Rakugi, Hiromi
    Shimamoto, Kazuaki
    Ito, Sadayoshi
    Matsuoka, Hiroaki
    Horiuchi, Masatsugu
    Imaizumi, Tsutomu
    Takishita, Shuichi
    Higaki, Jitsuo
    Katayama, Shigehiro
    Saito, Ikuo
    Shimada, Kazuyuki
    HYPERTENSION RESEARCH, 2009, 32 (02) : 163 - 167
12345